Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen versus benzydamine spray and cuff-directed versus oropharyngeal application for prevention of postoperative sore throat
TCTR20260921007Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Oct 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of flurbiprofen and benzydamine in Post-extubation sore throat (POST) (4 arms), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Primary endpoint: Severity of postoperative sore throat at rest within 24 hours postoperatively. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
flurbiprofenbenzydamine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on TCTR20260921007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260921007.